Literatur
Bowen EF, Wilson P, Cope A, Sabin C, Davey C, Johnson M, Emery V (1997) Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence, and survival. AIDS 10 (13): 1515–1520
Brown F, Arum I, Francis G, Patel M, Malcom S (1997) Ganciclovir prodrug (RS-79070) — multiple dose, dose-ranging study with effect of food. In: Abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D. C., January 22–26, 1997: 209. abstract
Davis JL, Serfass MS, Lai MY, Trask DK, Azen SP (1995) Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol 113: 1401–1409
Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, Leonard RE (1997) Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol 115: 733–737
Diaz-Llopis M, Espana E, Munoz G, Navea A, Chipont E, Cano J, Menezo JL, Romero FJ (1994) High dose of intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Br J Ophthalmol 78: 120–124
Dodt KK, Jacobsen PH, Hofmann B, Meyer C, Kolmos HJ, Skinhoj P, Norrild B, Mathiesen L (1997) Development of cytomegalovirus disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 11 (3): F21–28
Doornenbal P, Baarsma GS, Quint WG, Kijlstra A, Rothbarth PH, Niesters HG (1996) Diagnostic assays in cytomegalovirus retinitis: detection of herpesvirus by simultaneous application of the polymerase chain reaction and local antibody analysis on ocular fluid. Br J Ophthalmol 80: 235–240
Drew WL (1992) Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 14: 608–615
Driebe WT, Slonim CB (1995) Prevention of HIV transmission in the office and operating room. In: Stenson SM, Friedberg DN (eds) Aids and the eye. Contact Lens Association of Ophthalmologists, New Orleans, pp 23–34
Engstrom RE, Holland GN, Hardy WD, Meiselman HJ (1990) Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmologic microvasculopathy. Am J Ophthalmol 109: 153–161
Engstrom RE, Holland GN, Margolis TP, Muccioli C, Lindley JI, Belfort R, Holland SP, Johnston WH, Wolitz RA, Kreiger AE (1994) The progressive outer retinal necrosis syndrome. Ophthalmology 101: 1488–1502
Erice A, Gil-Roda C, Perez JL, Balfour HH, Sannerud KJ, Hanson MN, Boivin G, Chou S (1997) Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis 175: 1087–1092
Fabricius EM (1992) Manifestationen im Augenbereich. In: Fabricius EM (ed) Augenmanifestationen bei HIV-Infektionen. Ferdinand Enke Verlag, Stuttgart, 129, p 60
Fabricius EM (1992) Maßnahmen in der augenärztlichen Praxis. In: Fabricius EM (ed) Augenmanifestationen bei HIV-Infektionen. Ferdinand Enke, Stuttgart, pp 140–145
Flores-Aguilar M, Huang J, Clercq ED, Vuong C, Bergeron-Lynn G, Chandler B, Munguia D, Freeman WR (1994) Longacting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J Infect Dis 169: 642–647
Foreman KE, Friborg J, Kong WP, Woffendin C, Polverini PJ, Nickloff BJ, Nabel GJ (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma. N Engl J Med 336: 163–171
Freeman WR, Friedberg DN, Berry C, Quinceno JI, Behette M, Fullerton SC, Munguia D (1993) Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 116: 713–720
Gahbrila R, Quivey JM, Dunn JP, et al (1992) Radiation therapy of acquired immunodeficiency-related Kaposi’s sarkoma of the eyelids and conjunctiva. Arch Ophthalmol 110: 1423–1426
Gallant JE, Moore RD, Richmann DD, Keruly J, Chaisson RE, Zidovudine Epidemiology Study Group (1992) Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 166: 1223–1227
Garweg J, Fenner T, Böhnke M, Schmitz H (1993) An improved technique for the diagnosis of viral retinitis from samples of aqueous humor and vitreous. Graefe’s Arch Clin Exp Ophthalmol 231: 508–513
Geier SA, Klauss V, Bogner JR, Schmidt-Kittler H, Sadri I, Goebel FD (1993) Retinal detachment in patients with acquired immune deficiency syndrome. German J Ophthalmol 3: 9–14
Geier SA, Kronawitter U, Bogner JR, Hammel G, Berninger T, Klauss V, Goebel F (1993) Impairment of colour contrast sensitivity in patients with symptomatic HIV disease or acquired immunodeficiency syndrome. Br J Ophthalmol 77: 716–720
Gellrich MM, Baumert E, Rump JA, Hufert FT, Hansen LL (1996) Clinical utility of cytomegalovirus urine cultures for ophthalmic care in patients with HIV. Br J Ophthalmol 80: 818–822
Gellrich MM, Lagreze WD, Rump JA, Hansen LL (1996) Indikation zur Augenuntersuchung von HIV-Patienten — Screening-Parameter für CMV-Retinitis. Klin Monatsbl Augenheilkd 209: 72–78
Gerna G, Baldanti F, Sarasini A, Furione M, Percivalle E, Revello MG, Zipeto D, Zella D, Group TIFS (1994) Effect of foscarnet induction treatment of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob Agents Chemother 38: 38–44
Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY (1983) Acquired immune deficiency syndrom: ocular manifestations. Opthalmology 90: 859–873
Jabs DA, Enger C, Bustros S (1991) Retinal detachments with cytomegalovirus retinitis. Arch Ophthalmol 109: 794–799
Kuppermann BD, Assil KK, Vuong C, Besen G, Wiley CA, De-Clerq E, Bergeron-Lynn G, Connor JD, Pursley M, Munguia D, Freeman WR (1996) Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropy)cytosine for long-acting therapy of viral retinitis. J Infect Dis 173: 18–23
Kuppermann BD, Flores-Aguilar M, Quiceno JI, Capparelli EV, Levi L, Munguia D, Freeman WR (1994) A masked prospective evaluation of outcome parameters for cytomegalovirusrelated retinal detachment surgery in patients with acquired immune deficiency syndrome. Ophthalmology 101: 46–55
Kuppermann BD, Petty JG, Richmann DD, Matthews WC, Fullerton SC, Rickman LS, Freemann WR (1993) Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 115: 575–582
Kuppermann BD, Quiceno JI, Wiley C, Hesselink J, Hamilton R, Keefe K, Garcia R, Freeman WR (1994) Clinical and histopathologic study of varicella zoster virus in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 118: 589–600
Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Talamet C, Juhan-Vague I, Gastaut JA (1992) Endothelial cell dysfunction in HIV infection. Journal of Acquired Immune Deficiency Syndromes 5: 127–131
Lieberman R, Antoszyk A, Boyer D, Danis R, Duker J, Fish R, Goldstein D, Johnson D, Kuppermann B, Lambert M, Mansour S, Palestine A, Park S, Terry B, Vrabec T (1997) Antisense oligonucleotide (fomivirsen sodium) treatment of CMV retinitis unresponsive to other antiviral therapies. In: Abstracts of the Association for Research in Vision and Ophthalmology, Annual Meeting Fort Lauderdale, Florida, May 11–16th, 1997: 4227. abstract
Lucca JA, Farris RL, Bielory L (1990) Keratoconjunctivitis sicca in male patients infected with human immunodeficiency virus type I. Ophthalmology 97: 1008–1010
Mansour AM, Rodenko G, Dutt R (1990) Half-life of cottonwool spots in the acquired immunodeficiency syndrome. International Journal of STD and AIDS 1: 132
Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton RC, Remaley NA, Chew EY, Ashton P, Davis MD, Nussenblatt RB (1994) Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 112: 1531–1539
Marx JL, Kapusta MA, Patel SS, LaBree LD, Walonker F, Rao NA, Chong LP (1996) Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis. Arch Ophthalmol 114: 815–820
McCluskey P, Grigg J, Playfair TJ (1995) Retinal detachments in patients with AIDS and CMV retinopathy: a role for laser photocoagulation. Br J Ophthalmol 79: 153–156
Mitchell SM, Barton K, Lightman S (1994) Corneal endothelial changes in cytomegalovirus retinitis. Eye 8: 41–43
Möse JR (1996) Ruhe vor dem Sturm. Österreichische Ärztezeitung 9./10. Mai: 21–24
Mueller AJ, Geier S, Gürtler L, Klauss V (1994) HIV und Tränenflüssigkeit. Ophthalmologe 91: 663–667
Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD, The Ganciclovir Implant Study Group (1997) Treatment of Cytomegalovirus retinitis with a sustained-release ganciclovir implant. The New England Journal of Medicine 337: 83–90
Newsome DA, Green WR, Miller ED, Kiessling LA, Morgan B, Jabs DA, Polk BF (1984) Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol 98: 590–601
Pepose JS, Linette G, Lee SF, MacRae S (1989) Disinfection of Goldmann Tonometers against human immunodeficiency virus type 1. Arch Ophthalmol 107: 983–985
Rajeev B, Rao NJ (1995) Ocular pathological changes in acquired immunodeficiency syndrome. Seminars in Ophthalmology 10: 168–176
Rajnikant MA, Dean MT, Zaunmetzer LE, Poiesz BJ (1991) Virucidal efficacy of various lens cleaning and disinfecting solutions on hiv-1 contaminated contact lenses. AIDS Research and Human Retroviruses 7: 403–408
Sellitti TP, Huang AJ, Schiffman J, Davis JL (1993) Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am J Ophthalmol 116: 297–301
SOCA Research Group, in collaboration with the AIDS Clinical Trials Group (1992) Mortalitiy in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 326: 213–220
SOCA Research Group, in collaboration with the AIDS Clinical Trials Group (1994) Foscarnet — ganciclovir cytomegalovirus retinitis trial. 4. Visual outcomes. Ophthalmology 101: 1250–1261
SOCA Research Group, in collaboration with the AIDS Clinical Trials Group (1996) Assessment of cytomegalovirus retinitis. Arch Ophthalmol 114: 791–805
SOCA Research Group, in collaboration with the AIDS Clinical Trials Group (1997) Foscarnet — ganciclovir cytomegalovirus retinitis trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmol 124: 141–157
SOCA Research Group, in collaboration with the AIDS Clinical Trials Group (1997) Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus trail: a randomized, controlled trial. Ann Int Med 126: 264–274
Stenson SM (1995) Anterior segment manifestations of AIDS. In: Stenson SM, Friedberg DN (eds) Aids and the eye. Contact lens association of Ophthalmologists, New Orleans, pp 35–63
The Oral Ganciclovir European and Australian Cooperative Study Group (1995) Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 9: 471–477
Veloso AS, Zhu Q, Herrero-Vanrell R, Refojo MF (1997) Ganciclovir loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. Invest Ophthalmol Vis Sci 38: 665–675
Zurlo JJ, O’Neill D, Polis MA, Manischewitz J, Yarchoan R, Baseler M, Lane C, Masur H (1993) Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Int Med 118: 12–17
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ries, E., Ruhswurm, I., Krepler, K. et al. Der HIV-positive Patient. Spektrum Augeheilkd 13 (Suppl 25), 3–11 (1999). https://doi.org/10.1007/BF03162938
Issue Date:
DOI: https://doi.org/10.1007/BF03162938